Information Protection in Dark Web Drug Markets Research

dc.contributor.author Harviainen, J. Tuomas
dc.contributor.author Haasio, Ari
dc.contributor.author Ruokolainen, Teemu
dc.contributor.author Hassan, Lobna
dc.contributor.author Siuda, Piotr
dc.contributor.author Hamari, Juho
dc.date.accessioned 2020-12-24T19:58:23Z
dc.date.available 2020-12-24T19:58:23Z
dc.date.issued 2021-01-05
dc.description.abstract In recent years, there have increasingly been conflicting calls for more government surveillance online and, paradoxically, increased protection of the privacy and anonymity of individuals. Many corporations and groups globally have come under fire for sharing data with law enforcement agencies as well as for refusing to cooperate with said agencies, in order to protect their customers. In this study, we focus on Dark Web drug trading sites as an exemplary case of problematic areas of information protection, and ask what practices should be followed when gathering data from the Dark Web. Using lessons from an ongoing research project, we outline best practices for protecting the safety of the people under study on these sites without compromising the quality of research data gathering.
dc.format.extent 8 pages
dc.identifier.doi 10.24251/HICSS.2021.567
dc.identifier.isbn 978-0-9981331-4-0
dc.identifier.uri http://hdl.handle.net/10125/71184
dc.language.iso English
dc.relation.ispartof Proceedings of the 54th Hawaii International Conference on System Sciences
dc.rights Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject Social Shopping: The Good, the Bad and the Ugly
dc.subject dark web
dc.subject data scraping
dc.subject information protection
dc.subject online drug trading
dc.title Information Protection in Dark Web Drug Markets Research
prism.startingpage 4673
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0459.pdf
Size:
940.74 KB
Format:
Adobe Portable Document Format
Description: